Indication

Chronic myelomonocytic leukemia

Chronic myelomonocytic leukemia is a rare clonal hematopoietic malignancy classified as an overlap myelodysplastic syndrome/myeloproliferative neoplasm. Read more about Chronic myelomonocytic leukemia

25 drugs 25 manufacturers

Advertisement

Drugs that treat it

Common Chronic myelomonocytic leukemia therapies.

Showing 10–18 of 25 drugs

AZACITIDINE

PYRIMIDINE ANALOGS·MYELODYSPLASTIC SYNDROME·+2
NORTHSTAR RX LL

AZACITIDINE

PYRIMIDINE ANALOGS·MYELODYSPLASTIC SYNDROME·+2
ACCORD HEALTHCA

AZACITIDINE

PYRIMIDINE ANALOGS·MYELODYSPLASTIC SYNDROME·+2
ARMAS PHARMACEU

AZACITIDINE

PYRIMIDINE ANALOGS·MYELODYSPLASTIC SYNDROME·+2
DR.REDDY'S LAB

AZACITIDINE

PYRIMIDINE ANALOGS·MYELODYSPLASTIC SYNDROME·+2
APOTEX CORP
Filter & compare in the drug finder →Opens the drug finder with Chronic myelomonocytic leukemia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Chronic myelomonocytic leukemia.

Chronic myelomonocytic leukemia is a rare clonal hematopoietic malignancy classified as an overlap myelodysplastic syndrome/myeloproliferative neoplasm.

Primarily affecting the bone marrow and peripheral blood in older adults, it is characterized pathologically by sustained peripheral blood monocytosis alongside dysplastic myeloid precursors or excessive proliferation of mature myeloid lineages.

Clinical features typically include peripheral cytopenias, splenomegaly, constitutional symptoms, and an inherent risk of progression to acute myeloid leukemia.

Personalize your experience

Follow Chronic myelomonocytic leukemia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it